BioCentury | May 10, 2019
Emerging Company Profile

HopeMed: Targeting PRLR for chronic diseases

...HopeMed raised a $26 million series A round from Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
...Corporate partners: Bayer AG Number of employees: Undisclosed Funds raised: $26 million Investors: Trustbridge Partners, Qi Rui You Kang...
BioCentury | Apr 19, 2019
Finance

Hope for China’s academic spinouts

...AG (Xetra:BAYN), a $26 million series A round from Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
BioCentury | Apr 11, 2019
Company News

Hope Medicine in-licenses Bayer’s BAY 1158061

...pattern hair loss. Xiao is CEO of Hope Medicine. Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...and other chronic diseases associated with dysregulated PRL signaling. Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
Items per page:
1 - 4 of 4
BioCentury | May 10, 2019
Emerging Company Profile

HopeMed: Targeting PRLR for chronic diseases

...HopeMed raised a $26 million series A round from Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
...Corporate partners: Bayer AG Number of employees: Undisclosed Funds raised: $26 million Investors: Trustbridge Partners, Qi Rui You Kang...
BioCentury | Apr 19, 2019
Finance

Hope for China’s academic spinouts

...AG (Xetra:BAYN), a $26 million series A round from Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
BioCentury | Apr 11, 2019
Company News

Hope Medicine in-licenses Bayer’s BAY 1158061

...pattern hair loss. Xiao is CEO of Hope Medicine. Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...and other chronic diseases associated with dysregulated PRL signaling. Trustbridge Partners and Chinese PE firm Qi Rui You Kang...
Items per page:
1 - 4 of 4